Axial Biotherapeutics
Founded 2016 · $62.3M raised
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- axialbiotherapeutics.com
- Total Funding
- $62.3M
- Last Round
- $37.3M Series COct 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds for this company. The full record is or through the API.
About
Axial Biotherapeutics is a clinical-stage biopharmaceutical company developing therapies for central nervous system diseases and disorders. Its research uses the gut-brain axis to identify and develop novel treatments intended to improve patients' quality of life. The company advances therapeutic programs that translate microbiome and neurological science into potential medicines for CNS conditions.
Summary
Axial Biotherapeutics is a Biotech company, founded in 2016. It has raised $62.3M in total across 2 rounds, most recently a $37.3M Series C round in Oct 2021.
Funding History
Oct 2021
Sign up to see all 2 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/axial-biotherapeutics"><img src="https://indexed.vc/api/badge/company/axial-biotherapeutics" alt="Axial Biotherapeutics on Indexed.vc" width="260" height="76" /></a>